1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
(
- Contribution to journal › Article
-
Mark
Transcription Factor-Forced Astrocytic Differentiation Impairs Human Glioblastoma Growth In Vitro and In Vivo
(
- Contribution to journal › Article
- 2015
-
Mark
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
(
- Contribution to journal › Article
-
Mark
Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Epidermal Growth Factor-like Domain 7 Predicts Response to First-Line Chemotherapy and Bevacizumab in Patients with Metastatic Colorectal Cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article
- 2011
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
(
- Contribution to journal › Article
- 2009
-
Mark
Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.
(
- Contribution to journal › Article
- 2007
-
Mark
Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumor cells.
(
- Contribution to journal › Article